Xiaodong
Zeng
abc,
Liru
Xue
a,
Deliang
Chen
d,
Shanshan
Li
b,
Jinxia
Nong
b,
Bo
Wang
a,
Lin
Tang
b,
Qianqian
Li
b,
Yang
Li
b,
Zixin
Deng
bc,
Xuechuan
Hong
bce,
Mingfu
Wu
*ac and
Yuling
Xiao
*bc
aState Key Laboratory of Virology, Department Gynecology, Cancer Biology Research Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China. E-mail: mingfuwutj@163.com
bKey Laboratory of Combinatorial Biosynthesis and Drug Discovery (MOE), Hubei Province Engineering and Technology Research Center for Fluorinated Pharmaceuticals, Wuhan University School of Pharmaceutical Sciences, Wuhan, Hubei 430071, China. E-mail: xiaoyl@whu.edu.cn
cInnovation Center for Traditional Tibetan Medicine Modernization and Quality Control, Medical College, Tibet University, Lhasa, Xizang 850000, China
dJiangxi Key Laboratory of Organo-Pharmaceutical Chemistry, Chemistry and Chemical Engineering College, Gannan Normal University, Ganzhou, Jiangxi 341000, China
eInnovative Institute of Chinese Medicine and Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan 611137, China
First published on 28th November 2019
Correction for ‘A bright NIR-II fluorescent probe for breast carcinoma imaging and image-guided surgery’ by Xiaodong Zeng et al., Chem. Commun., 2019, DOI: 10.1039/c9cc07694h.
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
This journal is © The Royal Society of Chemistry 2019 |